Fig. 5From: IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosisIC100 concentration in tissues. Concentrations of IC100 in pg/μl in the brain, spinal cord, liver, and spleen of mice treated with IC100 at 10, 30, and 45 mg/kg or vehicle at 35 dpi EAE. Results are expressed as mean ± SEM of 5–10 mice/group. N.A., not assessed; N.D., not detectedBack to article page